CONMED Corp

CONMED Corp is a U.S.-based medical technology company focused on devices and equipment used in surgical procedures. Its portfolio spans orthopedic surgery and general surgery, with products used in sports medicine, lower-extremity procedures, minimally invasive laparoscopic and gastrointestinal surgery, electrosurgery, smoke evacuation, and cardiac monitoring. The company sells primarily to hospitals, surgery centers, surgeons, distributors, and large healthcare purchasing organizations, and it supports these customers through direct sales and distributor channels. CONMED manufactures substantially all of its products in the United States and Mexico and markets them globally, with a meaningful share of revenue coming from international markets. The business is characterized by a high mix of single-use products, which creates recurring demand tied to procedure volumes and installed capital equipment placements.

8,7 %

54,6 %

3,4 %

+5,2 %

2.14

1.01

— CONMED Corp
%
Orthopedic surgery42% Sports medicine, lower-extremity, small bone, large bone and powered surgical products used in orthopedic procedures.
General surgery58% Minimally invasive laparoscopic and gastrointestinal devices, electrosurgery, smoke evacuation, insufflation and monitoring products.

CONMED sells to a broad base of healthcare providers that use its devices in operating rooms and procedural suites...

  • Hospitals and health systemsprimary

    Buy orthopedic and general surgery devices for operating rooms, procedural suites and inpatient care, prioritizing reliability, breadth of portfolio and supply continuity.

  • Surgery centersprimary

    Purchase recurring single-use surgical products and capital equipment for outpatient procedures, where efficiency and procedure-specific performance matter.

  • GPOs and IDNsprimary

    Influence purchasing decisions for large healthcare networks that want fewer suppliers, standardized products and better pricing.

  • Medical specialty distributorssecondary

    Buy products for resale to healthcare providers, especially where customers prefer third-party inventory management and local distribution support.

  • Government and federal healthcare accountssecondary

    Includes Veterans Administration and other federal hospitals that buy through institutional procurement channels.

CONMED is headquartered in Largo, Florida and manufactures substantially all of its products in the United States and...

  • Headquartered in Largo, Florida, which anchors corporate and commercial operations
  • Manufacturing concentrated in the United States and Mexico
  • International sales are a large part of the business, around 44% of revenue
  • Principal overseas markets include Europe, Latin America, Canada and Asia/Pacific
  • Some sales go through third-party distributors, increasing channel dependence abroad
  • Exposure to tariffs and border taxes affects both U.S. imports and exports

CONMED's strategy centers on portfolio optimization, manufacturing efficiency and geographic diversification...

01
Portfolio optimization and product-line pruningshort-term

Management wants to focus resources on products that fit the core surgical strategy and improve margins.

02
Manufacturing and supply chain efficiencyshort-term

Inflation, tariffs and supply chain challenges are pressuring costs, so operational improvements are needed to protect profitability.

03
International growth and diversificationmedium-term

Management sees meaningful growth opportunities outside the U.S. and wants to reduce dependence on any single market.

CONMED faces demand risk tied to healthcare spending, procedure volumes and broader economic conditions, since its...

high

Dependence on healthcare procedure volumes

Revenue is tied to surgical procedures, many of which can be delayed during economic weakness, staffing shortages or public health disruptions.

Scope
Hospitals, surgery centers and distributors
Materiality
high
high

Product innovation and competitive pressure

The company competes against larger medical device firms with greater R&D and commercialization resources, which can reduce demand for CONMED products.

Scope
Orthopedic and general surgery franchises
Materiality
high
high

Tariffs and trade restrictions

Manufacturing and sales span the U.S., Mexico and international markets, so tariffs and border taxes can directly affect cost structure and pricing.

Scope
Cross-border supply chain and exports
Materiality
high
high

Transition away from Gore VIABIL and gastroenterology

The company is ending a distribution agreement that contributed meaningful sales, so replacement revenue and margin mix must be managed carefully.

Scope
Gastroenterology distribution
Materiality
high
medium

Regulatory and approval delays

Medical devices require approvals and clinical evidence, and delays can postpone launches or limit adoption of new products.

Scope
New product pipeline
Materiality
medium
Goodwill and intangible assets
Could create non-cash charges and affect equity and earnings
Contingent consideration
Can introduce periodic remeasurement gains or losses
Pension benefit obligation
Can move operating expense and balance sheet obligations
Product mix and revenue timing
Affects quarterly comparability and gross margin

: 11/08/2026